Durect announces positive results from phase 1b study of DUR-928 to treat NASH

Eric J Lawitz

Division of Gastroenterology

Press/Media: Press / Media

Period	May 28 2020

Media coverage

2

Media coverage

Title Durect announces positive results from phase 1b study of DUR-928 to treat NASH
Media name/outlet PharmaBiz
Country India
Date 5/28/20
Persons Eric J Lawitz
Title Durect announces positive results from phase 1b study of DUR-928 to treat NASH
Media name/outlet PharmaBiz
Country India
Date 5/28/20
Persons Eric J Lawitz